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Foreword 
 
For a better understanding of this study and the way it is structured, its story should be told. 
This project was undertaken during a 4-month period and it acts as my final thesis. I was an 
ERASMUS student at the University of Copenhagen, working in collaboration with the Danish 
Agriculture & Food Council (DAFC). 
When we first started to plan this study, we aimed to perform a full risk assessment including 
a source attribution. We intended to make use the so-called “OIE approach” which considers 
four major steps for a risk assessment: release assessment, exposure assessment, 
consequence assessment and risk estimation. Moreover, we were planning to estimate the 
number of human urinary tract infections and septicaemia cases caused by Extended-Spectrum 
Beta-Lactamases/AmpC Beta Lactamases-producing bacteria (ESBL/AmpC-PB) that could be 
attributed to each possible source per year in Denmark.  
However, this idea was abandoned due to lack of data that would enable us to perform an 
accurate risk assessment. Thus, we decided to select a different approach, using an exposure 
assessment to evaluate the relative role of meat for human ESBL/AmpC-producing E. coli 
(ESBL/AmpC-PEC) infections. 
This internship enabled me to be enrolled in several activities, which are listed in the 
Appendix III, and greatly contributed to my personal and academic development. From all of 
them, I would like to highlight the various presentations of the project I did. And also the 
granting of a bursary to attend the Society for Veterinary Epidemiology and Preventive Medicine 
(SVEPM) 2013 congress in Madrid, where I won a Poster Prize Award (Appendix IV). 
We also submitted the abstract of this project for oral presentation at the 10th International 
Conference on the Epidemiology & Control of Biological, Chemical and Physical Hazards in 
Pigs and Pork (Safe Pork 2013) this September in Portland (USA) and it will also be submitted 
to a peer-reviewed journal in the coming months. 
The thesis is composed by three main parts. The first part is the project addressing the 
exposure assessment of ESBL/AmpC-PEC in meat in Denmark. Few changes will be made to 
the version that will be submitted for peer-review. The second part is a consideration on the 
potential sources of ESBL/AmpC-PB. This part gives the reader a wider perspective on 
ESBL/AmpC and reflects on the state-of-art regarding the possible sources of this hazard and 
their potential implications for human health. The last part is a general conclusion of the entire 
project, focusing on future perspectives.  
This was a very challenging but rewarding internship, where I had the opportunity to work 
with great specialists in the Epidemiology/ Public Health field and perform a very interesting and 
actual study.  
 iii 
 
Summary 
 
Extended-Spectrum Beta-Lactamases (ESBL) and AmpC Beta-Lactamases (AmpC) are of 
great concern because of their ability to cause antimicrobial resistance in Enterobacteriaceae 
hampering the effect of treatment with beta-lactam antibiotics.  
The main objective of this study was to assess the relative importance of different types of 
meat for the exposure of consumers to ESBL/AmpC and their potential relevance for human 
cases in Denmark. 
This was assessed by weighting the prevalence of each genotype of ESBL/AmpC in 
imported and nationally produced broiler meat, pork and beef with the meat consumption 
patterns in Denmark. Data originated from the Danish surveillance programme for antibiotic use 
and antibiotic resistance (DANMAP) for 2009 to 2011. Data about human ESBL cases in 2011 
were also collected to assess a possible genotype overlap. 
Uncertainty was assessed by inspecting beta distributions of the genotype prevalences in 
each type of meat. 
Broiler meat represented the largest part of the estimated ESBL/AmpC contaminated pool of 
meat role (84.9%) compared to pork (11.5%) and beef (3.6%). CMY-2 was the genotype with 
the highest relative importance for human exposure (58.0%), and it was mainly isolated from 
broiler meat of either Danish or imported origin. However, CMY-2 is rarely found in humans in 
Denmark. 
In general the overlap between ESBL/AmpC genotypes in meat and those found in human E. 
coli infections isolates was limited. CTX-M-1 had a relative importance of 28.9% for human 
exposure through meat. Moreover, the prevalence of CTX-M-1 in humans was 7.3% of E. coli 
urinary tract infections and 8.0% of E. coli bloodstream infections. Hence, the genotype CTX-M-
1 was considered the most relevant genotype found in meat when referring to human exposure. 
This suggests that meat might constitute a less important source of ESBL/AmpC exposure of 
humans in Denmark than previously thought. More detailed surveillance data are required to 
determine the contribution of meat compared to other sources such as nosocomial infections, 
travelling, contact with animals, human-to-human transmission and the environment. 
 
Keywords: ESBL, AmpC, E. coli, meat, exposure assessment. 
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Exposure assessment of Extended-Spectrum Beta-Lactamases/AmpC 
Beta-Lactamases-producing E. coli in meat in Denmark 
 
1. Introduction 
 
Extended-Spectrum Beta-Lactamases (ESBL) were defined by the EFSA Panel on Biological 
Hazards (BIOHAZ) as plasmid-encoded enzymes found in the bacterial family 
Enterobacteriaceae, commonly in Escherichia coli and Klebsiella pneumonia. ESBL confer 
resistance to a variety of Beta-lactam antibiotics, including penicillins, 2nd, 3rd and 4th generation 
cephalosporins and monobactams (EFSA, 2011). The BIOHAZ panel also stated that AmpC 
Beta-Lactamases (AmpC) are intrinsic cephalosporinases found on the chromosomal DNA of 
many Gram-negative bacteria. However, the number of AmpC enzymes that are plasmid-borne 
is increasing (EFSA, 2011). An example of such plasmidic AmpC is CMY-2. 
 
1.1. Burden of disease 
The World Health Organization (WHO) calculated 25,000 deaths each year in the European 
Union (EU) due to infections with antibiotic resistant bacteria (WHO, 2011a). The increase of 
ESBL/AmpC is particularly worrying due to their resistance to 3rd and 4th generation 
cephalosporins, which have been considered critically important to human medicine by WHO 
(WHO, 2011b).  
 
 
Figure 1 – Proportion of 3
rd
 generation cephalosporin resistant isolates from E. coli bloodstream infections across 
Europe reported to EARS-Net from 2009 to 2011. Source: ECDC 2013 
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ESBL/AmpC-producing bacterial infections are on the increase worldwide (Pitout & 
Laupland, 2008). The European Antimicrobial Resistance Surveillance Network (EARS-Net) 
stated that no country from the 28 countries reporting to this programme demonstrated 
decreasing trends over the last few years (Figure 1) (ECDC, 2012). It should be noted that in 
2011 a high proportion of 3rd generation cephalosporin resistant E. coli isolates were ESBL 
producers. In line with this, for 2011, more than half of the countries reported proportions 
between 85% and 100% of 3rd generation resistant E. coli that were also ESBL 
producers(ECDC, 2012). The same occurred in previous years (ECDC, 2010, 2011). In 
Denmark, a steady increase has been observed from 2005 (1.1%) and through 2011 (8.5%) 
(Figure 2) (ECDC, 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The importance of the increase of ESBL/AmpC proportion among E. coli septicaemias can 
also be reflected in the augmented case fatality risk. Melzer & Petersen (2007) found a mortality 
risk of 23.7% in non-ESBL-producing E. coli septicaemias compared with 60.8% in ESBL-
producing E. coli (ESBL-PEC) bloodstream infections. It should be taken into account that these 
results might be overestimating the general ESBL mortality risk, because bacteraemia are 
frequently associated with critical underlying disease, delay in appropriate treatment and older 
age (Colodner et al., 2004; Nasa et al., 2012; Rottier et al., 2012; Trecarichi et al., 2012). A 
meta-analysis of 32 studies about the different outcome when comparing septicaemias by 
ESBL-producing and non-producing bacteria, found 2.32 higher odds of dying when infected 
with an ESBL producer. Even after adjusting for inadequate empirical treatment and sepsis 
severity, there was a statistically significant association (Rottier et al., 2012).  
 
Figure 2 – Proportion of 3
rd
 generation cephalosporins resistant E.coli from E. coli bloodstream infections in 
Denmark reported to EARS-Net from 2005 to 2011. Source: ECDC 2013 
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In general, the burden of antimicrobial resistance is quite significant. De Kraker et al. (2011) 
estimated for the year of 2007 in the 31 participating countries of the European Antimicrobial 
Resistance Surveillance System (EARSS) that 2,712 early deaths and 120,065 extra hospital 
days could be related to 3rd generation cephalosporins resistant E. coli bloodstream infections. 
Moreover, the same study calculated an economic burden of €18.1 million for the total costs 
related to the excess hospital stays (De Kraker et al., 2011).   
Another worrying fact is that ESBL/AmpC resistance leads to an increased use of 
carbapenems, since these compounds are widely regarded as the first choice for treatment of 
severe ESBL/AmpC infections (Paterson, 2000; Pitout & Laupland, 2008; Rupp & Fey, 2003). 
The use of this class of drugs is intrinsically related to the emergence of carbapenemases 
(Wilcox, 2009), which have the ability to hydrolyse all the beta-lactams and are extremely drug-
resistant, and therefore being a matter of great concern (EFSA, 2011). Additionally, it has been 
suggested that previous use of carbapenems may be a risk factor for occurrence of ESBL-PEC 
in patients with bloodstream infection (Martínez et al., 2006). 
 
1.2. Possible ESBL/AmpC-producing bacteria sources 
There are several potential ESBL/AmpC-PB sources that can be summarized in five major 
groups: foodborne, direct animals-to-human transmission, human-to-human transmission, 
environment and infections obtained abroad during travelling. Travelling is considered a source 
by itself since surveillance programmes are normally set at a national level. Moreover, it is more 
difficult to unveil the specific source when infection is acquired abroad. To our knowledge, the 
true importance of each of these possible sources for ESBL/AmpC dissemination and their 
relative relevance for human cases is unknown. 
Recently, a possible link has been highlighted to food and food-producing animals (EFSA, 
2011; SAGAM, 2009), stressing the importance of scrutinizing the role of food animal products 
to human ESBL/AmpC-PB infections.   
 
1.3. The Danish situation 
Denmark, as the other Nordic countries, has always been considered having a low animal 
prevalence of antimicrobial resistance, due to the conscious use and restrictive measures 
related to antibiotics. The “Yellow card” initiative (Alban et al., 2013) and the cephalosporins ban 
for use in pigs (Agersø & Aarestrup, 2013) are examples of the precautionary Danish policy 
related to antimicrobial use in animal production.  
From 2000 to 2008, DANMAP reports consistently showed very low prevalence of 3rd 
generation cephalosporin resistant bacteria both in live animals and in Danish meat (below 2%). 
ESBL have been reported in diagnostic submissions and have shown an increasing tendency 
over the years (DANMAP, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009). In 
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2009, the first surveillance study with enriched culture method was performed, nowadays 
described as the preferred method for ESBL/AmpC producers isolation (EFSA, 2011), followed 
by genetic background investigation (Agersø et al., 2012). Since then, this protocol has been 
repeated yearly, revealing an increasing prevalence in Danish broiler meat from 3% in 2009 
(data not published) to 44% in 2011 (DANMAP, 2011). In the same period, imported broiler 
meat had prevalences between 36% and 50% (DANMAP, 2009, 2010, 2011). 
 
1.4. Purpose of the study 
The aim of this project was to determine the relative importance of the various ESBL/AmpC-
PEC genotypes in different meat types with respect to exposure of Danish meat consumers. 
Moreover, the genotype overlap between isolates found in meat and human cases was 
evaluated to assess the relative importance of meat as a source of ESBL/AmpC-PEC infections 
in humans. 
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2. Materials and methods 
 
To assess the relative importance of each genotype and each type of meat for human 
exposure it was necessary to collect data about the meat available for consumption. This was 
divided into six categories: imported and domestically produced broiler meat, pork and beef. 
Furthermore, the prevalence of the different genotypes found in each category of meat were 
obtained. For this purpose, data from the surveillance programme DANMAP was used 
(DANMAP, 2009, 2010, 2011).  
 
2.1. Meat consumption patterns 
According to surveillance data from DANMAP 2011,  the frozen and chilled fresh meat 
available for consumption in Denmark were 128,200 tonnes of broiler meat, 198,800 tonnes of 
beef and 272,000 tonnes of pork (Figure 3) (DANMAP, 2011).  
Consumption was calculated as: Domestically produced – Exported + Imported (DTU, 2011).  
In 2011, 59.2% of all the meat available for consumption in Denmark was of domestic origin 
(DANMAP, 2011). A closer look at these data revealed that 64.7% of broiler meat, 50.5% of 
beef and 64.7% of pork were of Danish origin (DANMAP, 2011). 
There was no significant difference between the meat available for consumption in 2011 and 
the 2 previous years (DTU, 2011). 
 
2.2. ESBL/AmpC-producing E. coli occurrence in meat 
The data describing the ESBL/AmpC prevalence was collected from the Danish surveillance 
programme for antibiotic use and antibiotic resistance (DANMAP, 2009, 2010, 2011). In this 
programme detection of ESBL/AmpC-PEC is conducted using a selective culture method with 
 
Figure 3 – Fresh and frozen meat available for consumption in Denmark in 2011. Source: DANMAP 2011 
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antimicrobials. This method has a very high sensitivity and is qualitative, hence only resulting in 
positive or negative outcome. 
 
2.3. Relative importance of each type of meat for human exposure 
The relative importance of each type of meat and of each genotype was obtained by 
weighting the prevalence of ESBL/AmpC genotypes by the amount of meat available for 
consumption. DANMAP data were used for the prevalence values. Due to the low frequency of 
positive samples for pork and beef and the low frequency of testing in general, a pool of the 3 
years’ sampling was used.  
The genotype group “Others” included TEM-52 and unknown (i.e. where it was impossible to 
determine a specific genotype) in beef; unknown genotypes in pork; and TEM-20, TEM-52, up-
regulated AmpC and unknown genotypes in broiler meat (Appendix I). 
 
2.4. ESBL/AmpC-producing E. coli distribution 
Using the software @Risk 4.5 Palisade Corporation®, beta distributions were performed to 
assess the 95% credibility interval (CI) for each the genotype based on the sample data for 
each source. The main objective of this procedure was to conduct an uncertainty analysis and 
hereby estimate how high the true prevalence could be. 
The beta distributions were made through a simulation based on 1,000,000 iterations. The 
distributions were defined by (s+1, n-s+1), where s represents the number of positive samples 
for each genotype in each type of meat from 2009 to 2011, and n represents the total number of 
samples tested for ESBL/AmpC in each type of meat within the same 3-year period. 
The beta distribution output was the probability of occurrence of a number of positive 
ESBL/AmpC specific genotype in a determined type of meat. The number of positive samples 
represents a discrete outcome.  
Beta distributions were performed to take into account the uncertainty related to the low 
number of samples in the surveillance programme. This procedure was of particular relevance 
considering that some genotypes may have not been found through the Danish sampling 
surveillance and yet still be present in meat and play a role for ESBL/AmpC-PEC human cases. 
Their distribution was set as (0+1, n-0+1).  Actually, some genotypes were not found in meat 
during the surveillance programme, but were found in live animals. The beta distributions are 
shown in Appendix II. 
The lower the number of positive samples found, the lower the maximum prevalence that 
could be hiding in the meat.  
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3. Results 
 
3.1. Relative importance of each type of meat for human exposure 
As illustrated in Figure 4, during the period 2009 to 2011, broiler meat contributed the most to 
the total human exposure to ESBL/AmpC representing 84.8% of the total exposure. Danish 
broiler meat contributed with 36.8% and imported broiler meat with 48.0%. Danish pork 
constituted 5.4% of the ESBL/AmpC positive meat available for consumption, while imported 
pork represented 6.1%. Finally, beef seemed to have a minor relevance representing around 
3.6% (1.2% of Danish origin and 2.4% imported origin) of the total human exposure to 
ESBL/AmpC through meat. The relative importance of Danish broiler meat increased markedly 
from 2009 to 2011, while the relative importance of pork and imported broiler meat decreased 
between 2009 and 2011.  
 
 
Figure 4 – Relative importance of each type of meat and their respective origin to human ESBL/AmpC-PEC 
exposure, based on the data from 2009 to 2011. 
 
The relevance of each genotype varied between the 3 years, as shown in Figure 5. Most 
important, was the increase of the role CMY-2 in Danish broiler meat from 5.6% in 2009 to 
16.0% in 2010, increasing to 53.5% of the total exposure in 2011. Moreover, CMY-2 constituted 
the ESBL/AmpC genotype that meat consumers were most exposed to (58.0% across the 3-
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year period). Broiler meat was the source that contributed the most to this specific exposure 
(56.6% from broiler meat, 0.8% from pork and 0.6% from beef). 
CTX-M-1 was the most frequently isolated genotype in pork and beef: 7.7% and 2.4% of the 
total exposure, respectively. Including broiler meat, CTX-M-1 represented 28.9% of the total 
ESBL/AmpC positive meat in the Danish market from 2009 to 2011. 
 
 
 
 
Figure 5 – The relative importance of each type of meat for human exposure considering the genotypes found in 
DANMAP surveillance from 2009 to 2011. The beef genotypes are represented in blue colours, while pork is in pink 
and red, and broiler meat is in green, brown and yellow colours. 
 
Considering the origin of meat positive for ESBL/AmpC, a major shift occurred from 2010 to 
2011. Both in 2009 and 2010 Danish meat represented around 27% of the positive ESBL/AmpC 
meat contributing to human exposure, against 73% of imported origin. In 2011, the relative 
importance for human exposure of the Danish meat rose to 59% and the imported meat was 
41%. However, across the 3-year period, imported meat still contributed the most to the human 
exposure (57%). 
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3.2. Prevalence estimations for each genotype 
CTX-M-15 was the genotype most commonly found in human cases. It was found on rare 
occasions in Danish pigs and cattle at slaughter: two positive samples in 2009 (n=786) and one 
in 2011 (n=777) in pigs, and one positive sample in 2010 (n=192) and another in 2011 (n=186) 
in cattle. However, it has not been detected in meat samples so far. The same was the case 
with CTX-M-14. Through our calculations, it can be shown that these ESBL genes might be 
present in Danish pork and beef in an upper limit of the estimated prevalence of 0.7% and 
1.0%, respectively. 
The prevalence of CTX-M-1 in imported pork found by DANMAP was 0.2%, but there was a 
high degree of uncertainty due to the small number of positive samples. The estimated upper 
limit of prevalence for this genotype was 3.8% in imported pork. Both CTX-M-1 and CTX-M-14 
were found in human cases in Denmark. 
Imported broiler meat was the type of meat where the highest diversity of ESBL/AmpC genes 
was found through in the DANMAP programme. CMY-2 and CTX-M-1 had an upper limit of 
estimated prevalence of 24.5% and 17.9%, respectively.  
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4. Discussion 
 
This study evaluated the relative importance of various types of meat for the consumers’ 
exposure to ESBL/AmpC-PEC and their potential importance for human cases. We concluded 
that broiler meat was the type of meat that contributed the most for human exposure (84.8%), 
while CMY-2 was the genotype with the highest relative importance (58.0% of the total 
exposure through meat). However, this genotype has only been found in rare occasions in 
Danish human infections. 
A definitive cause-effect association cannot be established through our approach. A 
genotype overlay is not a proof that can be used for a proper source attribution, but the absence 
of a genotype overlap provides evidence against a possible link. Therefore, some inferences 
can be made. With this in mind, the limited genotype overlap between the two reservoirs 
indicate that meat might play a minor role for human cases of ESBL/AmpC-PEC.  
 
4.1. Data and methods 
A critical analysis should be done to the exposure assessment due to some possible bias 
that was not possible to avert. The meat consumption patterns were measured through the 
fresh and frozen meat available for consumption. This is the amount of meat which is in the 
market during a year, since it is calculated as: domestically produced – export + import (DTU, 
2011). The values used do not represent the amount of meat that was actually consumed. 
However, it was assumed that possible waste of meat occurred in the same proportion for all 
the types of meat.  
Moreover, the bacterial capacity to survive in frozen and fresh meat is different (Black et al., 
2010) and it was not taken into account. Once again, if the proportion between fresh and frozen 
meat is identical and considering the E. coli ability to survive in different types of meat similar, 
the final results are not affected.  
It was not possible to extend the study to other types of meat, as turkey or horse, due to lack 
of data on ESBL/AmpC-PEC prevalences. Nonetheless, this exposure assessment covers the 
three types of meat that represent the vast majority of meat consumed in Denmark. 
DANMAP reported high prevalences in imported broiler meat from 2009 to 2011; varying 
from 36% to 50% (DANMAP, 2009, 2010, 2011). Regarding Danish broiler meat ESBL/AmpC 
prevalence suffered a sudden increase in 2011 from 8.6% to 44% (DANMAP, 2011). 
Considering cephalosporins are not used in poultry in Denmark for more than 10 years it is 
possible that the problem is upstream in the production pyramid. This hypothesis has also 
arisen in Sweden (Börjesson et al., 2013; SVARM, 2010). Danish and Swedish broiler parents 
come from the same Swedish breeding stock, which in turn is supplied by a Scottish grand-
parent breeding company. It is possible that cephalosporins were used at this point of the 
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production chain as a prophylactic measure. Cross-contamination through the environment, 
humans or animals, as well as off-label use of cephalosporins, should also be considered and 
investigated. However, the fact that CMY-2 and CTX-M-1 were also the genotypes detected in 
Swedish broiler meat (SVARM, 2010) and both of them being the only ESBL/AmpC genes 
persistently detected in Danish broiler meat from 2009 to 2011, strengths the hypothesis of a 
common source upstream in the production pyramid. Co-resistance patterns may have 
facilitated the spread and maintenance of ESBL/AmpC-PEC (Börjesson et al., 2013). 
Transmission between flocks is also possible, although might represent a low contribution due 
to the all in/ all out policy and strict biosecurity implemented in Denmark. Nevertheless, the use 
of biocides for farm disinfection has been considered has a possible contributor for antimicrobial 
resistance (Schets et al., 2012). This problem should be investigated not only in broiler farms 
but also in cattle and pig farms. 
Imported broiler meat presented a great variety of genotypes (DANMAP, 2011), possibly due 
to the different importing countries and various causes of ESBL/AmpC emergence. 
 
  
Figure 6 – Antimicrobials sold in 2010 for veterinary 
purposes in several European countries adjusted with a 
population correction unit. Source: ESVAC 2010. 
Figure 7 – 1
st 
& 2
nd
 generation and 3
rd 
& 4
th
 generation 
cephalosporins sold in 2010 for veterinary use in several 
European countries. Measure adjusted with a population 
correction use. Source: ESVAC 2010. 
 
Denmark has one of the lowest antimicrobial uses in livestock of the EU and demonstrates a 
very prudent use of cephalosporins in animals (Figures 6 and 7)  (ESVAC, 2010). Although the 
use of cephalosporins in pig production was already low, a voluntary ban on this antimicrobials 
use was made in 2010 for this livestock sector (Figure 8). The discontinuation of its use is the 
most likely explanation for the reduction on the ESBL/AmpC-PEC prevalence seen in pigs in 
2011 (Agersø & Aarestrup, 2012). Other factors could also have contributed to this diminution. 
As the “Yellow card” initiative, adopted by the Danish Veterinary and Food Administration to 
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reduce the overall antimicrobial consumption, that took place almost at the same time and 
initially led to a 25% decrease in use of antimicrobials (Aarestrup, 2012; Alban et al., 2013).  
A decrease of the prevalence of ESBL/AmpC-PEC in pork from 1.9% in 2009 to 0.9% in 
2011 was also observed, although not statistical significant (Agersø & Aarestrup, 2012). 
 
 
Figure 8 – Kg of cephalosporins sold in Denmark for veterinary use. The increase seen in pets and 
cattle, and consequently in the total, from 2004 to 2005 is an artefact due to changes in the calculation 
method. Human data is not displayed. Since 2008, human consumption has been above 2500 kg. 
Source: DANMAP 2001-2011. 
 
4.2. The relative importance of meat and the overlapping with genotypes detected in 
humans 
The relative importance of each genotype found in meat for human exposure was calculated 
considering a 3-year pool. This may be considered a long period for prevalence estimation due 
to the explosive emergence and quick evolution of ESBL/AmpC, but resulted in a wider 
perspective of the situation. Furthermore, the procedure was also repeated for the 3 years 
separately. 
Some changes were observed in the relative importance of each genotype from 2009 to 
2011. Mainly minor shifts happened due to sporadic detection of some ESBL/AmpC genes and 
were due to the limited sample sizes. However, the most evident change occurred with the 
emergence of CMY-2 in Danish broiler meat from 5.6% in 2009 to 53.5% in 2011, having also 
repercussions on the relative importance of Danish broiler meat and Danish meat in general. 
This was due to the increasing prevalence of this genotype in Danish broiler meat. Especially, 
CMY-2 and CTX-M-2 in imported broiler meat and CTX-M-1 both in broiler imported meat and 
imported pork were consistently represented over the 3 years. 
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In humans, the so-called “pandemic CTX-M-15” genotype dominate both in blood and urine 
ESBL-PEC isolates, with 68.0% and 59.3%, respectively (Figure 9) (DANMAP, 2011). Results 
from 2007 are not as descriptive as the ones from 2011, but CTX-M-15 was approximately 
detected in 70% of the cases, while CTX-M-1 was found in roughly 5% of them (DANMAP, 
2009). In 2011, CTX-M-1 was detected in 7.3% of urine and 8.0% of blood isolates (DANMAP, 
2011). However, it should be noted that, particularly for human ESBL-PEC septicaemia, the 
number of cases on which these results are based is quite small (n=25). Subsequently, it is 
possible that the true ESBL genotype distribution is slightly diverse from what was found and 
some genotypes causing infections may have not been detected. 
 
 
 (A) n = 275 (B) n = 25 
 
Figure 9 – (A) – Proportion of each genotype detected in ESBL-PEC urinary tract infections in humans in 
Denmark in 2011. (B) - Proportion of each genotype detected in ESBL-PEC bloodstream infections in humans 
in Denmark in 2011. Source: DANMAP 
  
ESBL/AmpC genes found in humans and meat were, as previously described, only 
congruent to a limited extent. Just considering the detection of the same genotypes in both 
reservoirs (CTX-M-1 and CTX-M-14), only 24.0% of the urinary tract infections cases and 12.0% 
of the sepsis ones, in the worst case scenario, could be ascribed to meat.  
It should be highlighted, however, that although some genotypes were not found in meat they 
were found in live animals, indicating their possible presence in meat. This is the case of CTX-
M-15, which was detected in very low prevalences in Danish pigs and in Danish cattle. The very 
low prevalence probably explains the reason for why it was not detected in meat.  
This was one of the main motives which propelled us to perform an uncertainty analysis 
through the use of beta distributions. As expected, the mode prevalence was equal or very 
similar to the prevalence found in DANMAP and the uncertainty was higher with smaller sample 
sizes. This investigation is especially interesting to apply to genotypes that were found in live 
animals and not in meat. The maximum expected prevalence for ESBL/AmpC genes not 
detected in meat, considering the DANMAP sampling within the  3-year aforementioned period, 
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was 0.7% for Danish pork, 0.9% for imported pork, 1.0% for Danish beef, 1.4% for imported 
beef, 0.9% for Danish broiler meat and, finally, 0.7% for imported broiler meat. Through our 
calculations, these are the upper 95% credibility limit for the expected prevalences for CTX-M-
15 in each type of meat. Such low prevalence makes us doubt about a possible relevant role of 
meat for the CTX-M-15 producing E. coli infections in humans. Nonetheless, very little is known 
about the duration of carriage, dominance in the human gut microflora and different 
ESBL/AmpC’s ability to survive in human gut, to reach a definitive conclusion.   
The homogeneity of the ESBL/AmpC genes found in E. coli from imported beef is mostly 
likely a result of the very low number of positive samples: one positive sample per year. In 
Danish beef just two positive samples were found from 2009 to 2011, but from different 
genotypes (data not published). Due to this low prevalence, beef is the type of meat in which 
the uncertainty about the true ESBL/AmpC genotype distribution is the highest. It is advisable to 
increase the sampling process to achieve a better understanding of the genotype distribution in 
beef. 
It is of great relevance to highlight that CMY-2 was detected in human infections, but it was 
not possible to calculate its prevalence in humans. Nevertheless, the positive number of 
samples was low (data not published). CMY-2 is frequently seen in humans in the USA (ECDC, 
2012). Considering the possible emergence of CMY-2 E. coli and its high relevance for human 
exposure through meat, it is important that its prevalence is calculated in the upcoming years. 
 Depoorter et al. (2012) performed a quantitative exposure assessment to 3rd generation 
cephalosporin resistant E. coli through the consumption of broiler meat in Belgium, based to 
some extent on previous risk assessment models for Salmonella and Campylobacter. Although 
this study’s approach is different, Depoorter et al. (2012) also highlighted the lack of some 
important data to evaluate the impact of animal foodborne sources to human exposure. 
 
4.3. Control options 
Meat might not have such a high impact for human ESBL/AmpC-PEC infections as firstly 
thought. However, this does not exclude the importance of animal production, and even meat, 
for ESBL/AmpC dissemination. Therefore, and attending to the relevance of this subject, a 
precautionary approach should be taken. In Europe, the use of cephalosporins in poultry is 
prohibited and in Denmark a voluntary ban was implemented by the pig industry to their use in 
pigs in 2010. Cephalosporins are still used in Danish cattle, especially for intra-mammary 
injections, but Danish beef do not seem to be a relevant source of ESBL/AmpC exposure for 
humans. Regarding the high ESBL/AmpC-PEC prevalences in Danish broiler meat, measures 
have recently been taken to assure the non-use of cephalosporins on the top of the production 
pyramid (Jan Dahl, DAFC, personal communication, 2013).  
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In Denmark, there are limited new options to control ESBL/AmpC occurrence through the 
reduction of cephalosporins use in livestock. It is known that other antimicrobials can co-select 
ESBL/AmpC genes. Therefore, measures to promote the reduction of antimicrobial use in 
general, such as the “Yellow card” scheme, may have some influence.  
However, downstream the production chain, other options can be explored. In first place, 
some studies have documented the existence of some risk factors for ESBL/AmpC growing in 
animals’ gut (Persoons et al., 2010). The impact of probiotics in the control of this type of 
bacteria should also be studied. 
Secondly, cross contamination during slaughter should be inspected and, if relevant, hygiene 
should be improved. Other option to consider is to implement decontamination after slaughter. 
Animal trade has been considered a promoter of ESBL/AmpC dissemination. DANMAP has 
consistently reported higher prevalences of ESBL/AmpC-PEC in imported meat, suggesting that 
non-Danish produced meat involves a higher risk of being exposed to ESBL/AmpC-PEC.  
European common measures should preferably be implemented to fight this hazard, rather than 
individual, national policies.  
 
 
Table 1 – Suggested measures to control ESBL/AmpC-PB. 
Possible source Measures 
Human-to-human 
and nosocomial 
infections 
 Improve hospital hygiene 
 Stricter guidelines, both for hospital and community use of 
cephalosporins 
Animal-to-human 
transmission 
 Stricter guidelines for the use of cephalosporins in pets 
Travelling  International measures to control  ESBL/AmpC-PB  
 Advice to travellers about hygiene measures to prevent 
becoming infected with  ESBL/AmpC-PB 
Environment  Reduce the use of cephalosporins and antimicrobials in 
general; this should decrease  ESBL/AmpC-PB dissemination 
Foodborne  Reduce the use of cephalosporins and other antimicrobials in 
general in livestock 
 Production measures to reduce  ESBL/AmpC-PB 
dissemination 
 Improve slaughter hygiene 
 Decontamination after slaughter 
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Nonetheless, a judicious use of resources must be done. In that sense, the role of other 
sources should be assessed, inclusively for other foodborne sources. This would allow us to 
point the reservoir where most effort should be applied to control ESBL/AmpC-PEC. Table 1 
present some general measures to control ESBL/AmpC-PEC, and ESBL/AmpC-PB in general. 
It is possible that meat is the source for at least a small part of the human cases, but to 
obtain more precise conclusions, further studies need to be performed. ESBL/AmpC-PB is a 
very complex subject and their emergence, ecology and dynamics is nowadays poorly 
understood. 
As previously mentioned, a wider study about the ESBL/AmpC genotypes in human cases in 
Denmark is necessary. An extensive characterization of human patients must be done. 
Moreover, CMY-2, and other AmpC, prevalence need to be calculated. 
Just one study has been performed about the duration of carriage and prevalence in healthy 
individuals in Denmark. Hammerum et al. (2011) performed a study in healthy army recruits. 
From 84 participants, 7% were carriers of ESBL/AmpC-PB, suggesting the existence of a 
human reservoir. Additionally, studying the risk factors in healthy humans could be a relevant 
step for source attribution and important to prioritize control measures. The relevance of 
ESBL/AmpC carriage for the occurrence of community acquired and nosocomial infections 
should also be assessed.  
Furthermore, very little is known about the impact of control strategies, which hampers 
prioritisation of measures to prevent the emergence and dissemination of ESBL/AmpC-PB. This 
is a critical point that must be further investigated urgently. 
Finally, we suggest that data collection, in human, food and animal reservoirs, become 
harmonized across the EU. This would not only allow us to actually compare data between 
countries, but also facilitates to study risk factors and suggest optimal control strategies.  
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5. Conclusions 
 
Lack of data disabled us from performing a full risk assessment for ESBL/AmpC-PB with 
source attribution. However, we were able to undertake an exposure assessment to evaluate 
the relative role of meat for ESBL/AmpC human cases. 
Our study concluded that poultry meat is the most relevant for human ESBL/AmpC-PEC 
exposure, followed by pork and beef. In general, Danish meat has a lower relative importance 
compared with imported meat. Nevertheless, the prevalence of ESBL/AmpC-PEC in Danish 
broiler meat significantly increased in 2011, leading to a considerable growth in its relative 
importance. High prevalences in broiler meat are probably related to cephalosporins use in the 
top of the production pyramid and measures are being taken to control the problem. 
CMY-2 was the ESBL/AmpC gene seen in meat with the highest relevance for food safety. It 
was detected in low proportions in human infections, but its prevalence in humans was 
impossible to calculate. We suggest that this situation should be carefully followed and CMY-2 
prevalence in urinary and bloodstream human infections should be calculated. 
CTX-M-1 and CTX-M-14 producing E. coli were found in both human and animal reservoirs, 
but the relevance of both genotypes for human infections is not very significant. 
“Pandemic” CTX-M-15 was not found in meat samples. Nonetheless, it should not be ruled 
out the possibility of its existence in meat, especially because it has previously been detected in 
live animals, although at a low prevalence. 
The complexity of this subject has not been transposed. A better understanding of the entire 
problematic is required, unveiling the factors that lead to ESBL/AmpC emergence and 
explaining the interface between several sources and humans. This may turn it possible to 
clarify the increasing occurrence of human cases. With that purpose, future studies are urgently 
needed, especially to complement the data on the human side.  
In conclusion, the genotype overlap between the two reservoirs – human and animal - is 
small, suggesting that meat might not have such a relevant role for ESBL/AmpC-PEC human 
infections in Denmark as it was firstly thought. 
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Review on ESBL/AmpC-producing bacteria potential sources 
 
This chapter intends to provide an overview on the current knowledge about the several 
possible sources of ESBL/AmpC-PB. These potential sources can be gathered into five major 
groups: foodborne, human-to-human transmission, animal-to-human transmission, environment 
and acquired abroad during travelling. 
 
1. Foodborne 
 
1.1. Meat 
Meat has been extensively discussed as a potential source of ESBL/AmpC-PB, taking the 
Danish situation as an example. Nevertheless, some Dutch studies assign a more important 
role of retail chicken meat and poultry meat as vectors for ESBL/AmpC-PB transmission to 
humans (Kluytmans et al., 2013; Leverstein-van Hall et al., 2011; Overdevest et al., 2011). In 
fact, the predominant ESBL genes found in chicken meat were identical to the ones found in 
human rectal specimens (Overdevest et al., 2011). These differences between the Dutch and 
Danish situations may be due to the higher livestock’s antimicrobial use in the Netherlands 
compared to Denmark. However, it should be noted that these studies do not reached a 
definitive conclusion or any cause-effect association between meat consumption and the 
occurrence of ESBL/AmpC-PB related infections. 
ESBL/AmpC-PB were detected in other animals, such as ducks, rabbits, turkeys or ostriches 
(Blanc et al., 2006; Carneiro et al., 2010; Ma et al., 2012; Randall et al., 2011), thus, all these 
types of food-producing animals are potential sources for human gut colonization by 
ESBL/AmpC-PB. Furthermore, game animals have also been identified as possible reservoirs 
(Poeta et al., 2009). However, the role of these types of potential meat for ESBL/AmpC-PB 
acquisition by humans is not fully understood, but is likely to have less impact than the meat of 
domesticated animals. 
 
1.2. Fish 
1.2.1. Wild fish 
Regarding wild fish, it is well known that the antimicrobial pressure they suffer is much lower 
than the antibiotic stress experienced by aquaculture fish. Still, wild fish may be exposed to 
ESBL/AmpC-PB due to water contamination with faecal content of other animals and humans.  
Sousa et al. (2011) assessed the carriage of ESBL-PEC in the faecal samples of Sparus 
aurata captured in the West coast of Portugal. From 118 analysed samples, five were ESBL 
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positive (4.2%), being TEM-52 and SHV-12 the genotypes detected. Thus, this study suggests 
that wild fish can be a reservoir and a potential vehicle to ESBL-PEC human infections.  
 
1.2.2. Aquaculture fish 
Aquaculture fish are exposed to various stressors, ranging from physical to chemical, caused 
by human intervention (due to processes to enhance production, such as regular stocking, 
feeding, protection from predators) and  several other environmental constrains (Barton, 2002; 
Cabello, 2006; Naylor & Burke, 2005; Sørum, 2006). This generally has negative repercussions 
in the fish immune system, increasing the possibility of infections and their rapid spread. 
Moreover, the widespread and unrestricted use of prophylactic antibiotics in the industry of 
aquaculture, commonly used to prevent bacterial infections resulting from sanitary shortcomings 
in fish rearing, normally remain in the aquatic environment, exerting their selective pressure for 
long periods of time and, thus, leading to the emergence of antibiotic-resistant bacteria in these 
aquaculture environments (Cabello, 2006). Although the use of cephalosporins in aquaculture is 
not authorized (Serrano, 2005) (except in properly justified situations), the extend use of other 
antimicrobials may lead to the emergence of ESBL/AmpC-PB due to co-resistance patterns. 
Additionally, sometimes water contamination with antibiotics may be originated from sewage, 
agriculture or industrial wastewater (Cabello, 2006). 
In Asia, the Integrated Multi-Trophic Aquaculture (IMTA), in which the by-products (wastes) 
from one species (fish or terrestrial animals) are recycled to become food for another, is a 
common practice (Cabello, 2006; Dang, et al., 2011; Petersen & Dalsgaard, 2003). This 
facilitates the transmission of ESBL/AmpC-PB from terrestrial animals to aquaculture fish. 
To our knowledge there are no studies performed in Europe to evaluate the existence of 
ESBL/AmpC-PB in aquaculture fish. Jiang et al. (2012) found an ESBL-PEC prevalence of 1.5% 
in farmed fish in China, while Ishida et al. (2010) found 5.1% prevalence in Egypt. However, it 
should be highlighted that both studies used non-selective culture methods. 
Alderman & Hastings (1998) suggested that the risk for the public health resulting from the 
usage of antimicrobial agents in aquaculture was very low. Presently, this still probably be true 
in Europe and North America where decreasing trends in the use of antibiotics in aquaculture 
have been observed, mostly due to more restricted legislation apply to this industry (Heuer et 
al., 2009; Petersen & Dalsgaard, 2003). However, the same is not applicable to the Asian 
continent. Asia, leaded by China, have the largest world’s aquaculture environment (Heuer et 
al., 2009; Jiang et al., 2012), supplying European countries with great amounts of aquaculture 
fish, which is imported frozen and despite reducing the microbial load, the risk of bacterial 
contamination should also be assessed.  
To date there are no studies reporting the presence of ESBL/AmpC-PB in fish meat, 
hindering the implementation of an exposure assessment. Sørum (2006) stated that the transfer 
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of antimicrobial resistant determinants between human and fish bacteria occurred much faster 
than the same process with terrestrial animal husbandry. This highlights the need to study and 
control ESBL/AmpC-PB emergence in fish. 
 
1.3. Milk and milk products 
ESBL/AmpC-PB have been found in milk and milk products (Amador et al., 2009; Gundogan 
& Yakar, 2006). That is not surprising once cows are often exposed to antibiotics. Moreover, 
cephalosporins are commonly used to treat mastitis and for the dry-cow therapy (Merck, 2012). 
Actually, in Denmark, the majority of the cephalosporins used in cattle are intra-mammary 
injections (DANMAP, 2011). The biggest issue is that cephalosporins are excreted in milk.  
Ultra pasteurized milk is not likely to carry any bacteria. However, some products made with 
raw or pasteurized milk may constitute a route for ESBL/AmpC-PB transmission to humans 
(Amador et al., 2009; Gundogan & Yakar, 2006). The same is also true in the case of milk from 
other animal species, such as ewe or goat (Amador et al., 2009).  
Amador et al. (2009) found that 80.9% of the Enterobacteriaceae isolates from 6 different 
types of Portuguese cheese harbored genes from the TEM ESBL family. No CTX-M or SHV 
ESBL family genes were detected.  
Gundogan & Yakar (2006) assessed the presence of ESBL-producing Klebsiella species in 
Turkey in raw and pasteurized milk, white cheese and ice cream. ESBL-producing Klebsiella 
were detected in the four types of samples, with an average prevalence of 35% (n=43).  
These studies reflect the need to control the presence of these bacteria in the milk, but also 
to improve the good hygienic practices during milking and production of cheese. 
 
1.4. Eggs 
The importance of the egg as an ESBL/AmpC-PB source is not well documented (Egea et 
al., 2011). Moreover, there is limited data on the prevalence of ESBL/AmpC-PB in the chicken 
egg production.  
It is relevant not only to assess the importance of the egg as an ESBL/AmpC-PB vehicle 
aliment, but also the possibility of cross contamination in the kitchen through the eggshell. 
Bortolaia et al. (2010) investigated the occurrence of ESBL-PEC in flocks of chicken egg 
layers reared in Danish organic systems. From de 60 cloacal swabs collected from live animals, 
3% were positive for CTX-M-producing E. coli. The beta-lactamase genes found were from de 
groups CTX-M-1, -2, -9 and TEM-1. It must be noted that this study was conducted in organic 
farms where the antimicrobial use is generally lower. Actually, there was no history of 
antimicrobial or biocide use on the farms where the samples were collected. 
Egea et al. (2011) assessed the possibility of eggshell contamination with ESBL-PEC, by 
analysing 72 eggshells from several supermarkets and no positive samples were found.  
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The sanitation procedures for chicken eggshells may also explain the absence of 
ESBL/AmpC-PB on this product. In the EU, washing egg procedures are not allowed, but other 
processes (gaseous ozone, chloride ultraviolet radiation, dirty eggs exclusion) are applied in 
order to reduce the coliform load, what may contribute to the nonappearance of ESBL/AmpC-
PB in the above mentioned study. 
The available data on this subject is scarce and more studies should be conducted to 
accurately assess the importance of eggs in the transmission of ESBL/AmpC-PB.  
 
1.5. Fruits and vegetables 
The existing microflora on raw fruits and vegetables is usually harmless for the human 
health, although pathogenic microorganisms are occasionally found. Several human infection 
outbreaks resulting from vegetables or fruits contamination have been reported (Beuchat, 
2002). A recent example was the presence of  E. coli O104:H4 in sprouts that caused an 
outbreak in Germany (Buchholz et al., 2011).  
Furthermore, fruits and vegetables may be contaminated with resistant bacteria at any point 
from production to consumption (Hassan et al., 2011; Österblad et al., 1999). The use of 
antibiotics during cultivation, use of contaminated water or contaminated fertilizers may 
enhance the colonization of fruits and vegetables by resistant bacteria (Österblad et al., 1999). 
Hassan et al. (2011) performed a study to assess the bacterial load and the occurrence of 
some disease-causing enteric bacteria on raw vegetables sold in Saudi markets and found that 
2.3% of the isolates were ESBL producers and 14.8% were resistant to extended-spectrum 
beta-lactam antibiotics. Other studies did not found ESBL/AmpC-PB, but found resistance to 
first and second generation cephalosporins in isolates from vegetables, fruits and fruit juice 
(Hamilton-Miller & Shah, 2001; Lateef et al., 2004; Österblad et al., 1999) 
Antibiotic resistant bacteria detection in fruits and vegetables is particularly worrying since 
these products are often eaten raw. Moreover, they may constitute a risk for kitchen cross-
contamination. Future studies need to be performed to cover the little data available on the 
subject and to assess the role of these products in ESBL/AmpC-PB human infections.   
 
2. Human-to-human transmission 
 
Humans are also an ESBL/AmpC-PB reservoir. The increase number of carriers leads to an 
increased risk of other individuals become carriers as well (Levin, 2001; Valverde et al., 2004). 
Besides the study on army recruits in Denmark (Hammerum et al., 2011), few studies were 
performed to assess ESBL/AmpC-PB carriage in healthy individuals. Geser et al. (2012) found 
that 5.8% of the faecal samples collected from 586 humans in Switzerland yielded ESBL 
producers, confirming the existence of a human reservoir. 
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Duration of carriage has not been extensively studied and the results available show great 
variability. Alsterlund et al. (2012) found that carriage could last more than 58 months, after 
following patients from an ESBL outbreak. Apisarnthanarak et al. (2008) detected an average 
ESBL-producing bacteria (ESBL-PB) carriage of 98 days among outpatients, during a 6 month 
follow-up. It is of great relevance to study the factors that influence these variations in the time 
of carriage of ESBL-PB by unhealthy patients, as well as to determine the duration of carriage in 
healthy individuals. 
The increase of carriers in the community, and consequently of the resistome, may 
jeopardize the decrease of the ESBL/AmpC-PB in nosocomial settings (Lipsitch & Samore, 
2002; Valverde et al., 2004).  
Indeed, nosocomial ESBL/AmpC-PB infections may have a very important role, especially 
when considering severe infections. Before 2000, the majority of the ESBL cases were 
nosocomial, often caused by Klebsiella spp. (Livermore et al., 2007). It is of great relevance to 
determine the proportion of ESBL/AmpC-PB infections that are nosocomial. A great number of 
these infections may lead us to focus more on the hospital practices and hygiene. 
 
3. Animal-to-human transmission 
 
3.1. Pet animals 
Regarding companion animals, ESBL/AmpC-PB transmission should be observed as a 
bidirectional phenomenon, driven by the close contact of the two reservoirs; it is well known that 
pets are commonly  let free inside the house and  close face-to-fur contact is very frequent 
(Wieler et al., 2011). Additionally, considering meat a possible vehicle of ESBL/AmpC-PB, pets 
often eat the same food of their owners, which can select the same gut microflora in both 
reservoirs. Considering these factors, it is not surprising that several studies found similar 
ESBL/AmpC genotypes in humans and pets, including the CTX-M-15 genotype (Costa et al., 
2008; Damborg et al., 2011; Ewers et al., 2010; Huber et al., 2013; Lefebvre et al., 2006; 
Tamang et al., 2012; Wedley et al., 2011). Meyer et al. (2012) suggested that having pet 
animals could be a risk factor for human ESBL-PB acquisition. Nonetheless, this study is based 
on a very limited number of positive samples (n=8).  
The status of family member that pets gained during the last decades also changed the 
perception of welfare and the expected medical care services. This led to no differences 
between the antimicrobials used for human and pet treatments and also to an increase in 
antimicrobial usage in companion animals. The use of cephalosporins in pet animals has been 
on the rise (Peter Damborg et al., 2011) and strong evidences have shown that their use  
contributed for ESBL/AmpC-PEC appearance in dogs and horses (Damborg et al., 2009; 
Damborg et al., 2012) 
 23 
 
Compared to food-producing animals, little attention has been given to companion animals 
regarding the possibility of ESBL/AmpC-PB transmission to humans. With rare exceptions, 
surveillance programmes do not include pet animals (Guardabassi et al., 2004). However, 
considering the actual knowledge, the role of companion animals should not be neglected. 
 
3.2. Contact with farm animals 
Considering that farm animals are ESBL/AmpC-PB reservoirs, humans may be exposed not 
only through meat, but also by direct contact. 
Moodley & Guardabassi (2009) investigated the transmission of plasmids carrying ESBL 
genes between pigs and farm workers. The results indicated that there was, indeed, 
transmission of these mobile elements between the reservoirs. If farm workers are at a higher 
risk of carriage of ESBL/AmpC-PB, their importance as carriers should be investigated. 
More recently, Huijbers et al. (2013) performed a study in the Netherlands to assess if living 
in areas of high broiler densities could implicate a higher risk of carrying ESBL-producing 
Enterobacteriaceae. However, this hypothesis was not confirmed. It should be noted that 
several factors may have influenced the results.  
The importance of contact with farm animals may be extended to other species. Kozak et al. 
(2009) found that small rodents living nearby pig farms carried antimicrobial resistant E. coli 
more frequently than the ones living in natural areas. Furthermore, it seemed to occur an 
association between the type of resistance found in pigs and small rodents. However, the 
sampling was too small to prove it statistically. This suggests that animal production may also 
have impact on the bacterial resistance found in wild animals. 
 
3.3. Wild animals 
ESBL/AmpC-producing bacteria have also been reported in wild animals (Bonnedahl et al., 
2009; Costa et al., 2006, Costa et al., 2008; Guenther et al., 2010; Literak et al., 2010; Pinto et 
al., 2010; Poeta et al., 2009; Silva et al., 2011; Simões et al., 2010; Simões et al., 2012) and 
some of them harbour the same genes detected in human cases. Considering that no apparent 
exposure had occur in these animals, resistance bacteria should not be confined within the 
reservoir where resistance emerged (da Costa et al., 2013). 
Wild animals may contribute to the maintenance and dissemination of ESBL/AmpC-PB. This 
has especial interest for public health when these animals’ habitat is in urban areas and, thus, 
the contact with humans is closer. That is the case of seagulls. Simões et al. (2010) found that 
32% of E. coli isolated from seagull faeces in beaches of Porto region, in Portugal, were ESBL 
positive. Moreover, CTX-M-15 was the most detected genotype, as well as it was in another 
study involving hospitalized patients in Porto (Machado et al., 2006). This may raise the 
possibility of a link between the two reservoirs, seagulls and humans.  
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4. Environment 
 
As da Costa et al. (2013) stated: “The environment is the melting pot of antimicrobial 
resistance”. Environmental niches may play a central role for ESBL/AmpC dispersion and 
maintenance and their relevance have been neglected. The actual number of genotypes within 
the environmental resistome is not known and the acquisition of these genes by human 
pathogens is also not well studied (Allen et al., 2010; da Costa et al., 2013).  
Through the dispersion of antimicrobial residues, these molecules may still exert selective 
pressure far away from the place where they firstly were used (Allen et al., 2010; Tello et al., 
2012). The sewage released from hospitals and pharmaceutical industries (Guardabassi et al., 
1998) plays an important role in the dissemination of resistant genes in the environment. 
Additionally, horizontal gene transfer may occur between commensal and pathogenic bacteria. 
Wastewater treatment plants are potential hotspots for antimicrobial resistance acquisition 
through horizontal gene transfer (Guardabassi et al., 2002). Moreover, effluent treatments do 
not guarantee that antimicrobial resistant bacteria are not released in the receiving water and 
so, dispersed in the environment (Reinthaler et al., 2003).  
Currently, no sewage treatment is able to eliminate selective antibiotic concentrations (da 
Costa et al., 2013). This is an important topic for future studies that could help us breaking the 
antimicrobial resistant bacteria cycle. 
Zarfel et al. (2013) found, in Austrian sewage sludge, ESBL-PEC genetically identical to the 
bacteria detected in human urinary tract infections, suggesting the possibility of recirculation of 
these genes. Thermal treatment and lime stabilization followed by dehydration was suggested 
as the preferable method to reduce pathogen concentration in sewage sludge (Reinthaler et al., 
2010). However, it is not possible to guarantee that no ESBL/AmpC-PB are in the sludge and, 
therefore, its use as fertilizer can contaminate the environment (da Costa et al., 2013) 
The spread of ESBL/AmpC-PB in the environment and their transmission to new hosts is one 
of the most complex topics related with this subject. This is due to the numerous possible 
pathways and influencing factors on the spread of these antimicrobial resistance genes. 
 
5. Travelling 
 
ESBL/AmpC-PB acquisition while travelling abroad is considered a source per se since the 
ESBL/AmpC reality varies between countries and the risk to acquire these bacteria is different 
considering diverse parts of the world (Meyer et al., 2012; Tängdén et al., 2010). Furthermore, 
surveillance programmes are normally performed at a national level and so, is more adequate 
to consider travel abroad separately. Additionally, the true source is commonly more difficult to 
determine in abroad acquired infections.  
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Few studies were performed to evaluate the role of travelling in the acquisition of 
ESBL/AmpC-PB and some of them have important limitations. Meyer et al. (2012) identified 
travel to Greece and to Africa as potential risk factors for colonization with ESBL-PEC. 
However, it should be noted that these conclusions are based on a very small number of 
positive ESBL samples (n=8) and therefore can be considered speculative. Tham et al. (2010) 
assessed the prevalence of ESBL-PEC in stool samples of Swedish patients with travellers’ 
diarrhoea. ESBL-PEC was found in 24% of the patients analysed (n=242). Nonetheless, stool 
samples were not collected before travelling abroad, so it is not possible to know if the patient 
was already carrying the resistant bacteria before travelling or not.  
In a study performed by Tängdén et al. (2010), faecal swabs were collected from 100 
volunteer individuals before and after travelling. No one had ESBL-producing Enterobacteriacea 
before travelling. After their return, 24 were already ESBL-PB carriers. 
In developing countries, the prevalence of antimicrobial resistant bacteria is commonly higher 
due to poor hygiene, lack of antimicrobial usage control, overcrowding and absence of good 
sewage disposal systems (Memish et al., 2003; van der Bij & Pitout, 2012). Currently, a 
considerable number of people from developed countries is travelling to developing countries in 
order to do surgical procedures there, to avoid longer waiting times and benefit from lower 
treatment costs (Van der Bij & Pitout, 2012). It is estimated that this “medical tourism” to India, 
for instance, will increase around 30% each year until 2015 (Pitout, 2010). This is particularly 
worrying considering that hospitalization has been suggested as a risk factor for ESBL-PB 
colonization (Colodner et al., 2004).  
Additionally, Freeman et al. (2008) stated a higher risk of urinary tract infections caused by 
ESBL-PEC among New Zealand travellers to India. Moreover, in this study, 3 out of 10 patients 
had a relapse after treatment with carbapenems. 
Globalization and the easy access to travel are facilitating the spread of ESBL/AmpC-PB. 
Travelling to countries with high prevalence of ESBL/AmpC-PB can be considered a risk factor 
for colonization and may be a relevant vehicle for ESBL/AmpC-PB dissemination within the 
population. Joint efforts are mandatory to fight adequately this problem. 
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Final comments 
 
ESBL/AmpC-PB is a very complex issue, with a very intricate network of connections and 
influencing factors. These bacteria prevalence and spreading is not well understood, neither 
controlled. 
The great mobility of ESBL/AmpC genetic material helps to explain their dissemination 
through several ecological niches and adds an extra layer of complexity to control this public 
health problem.  
The absence of knowledge on the effectiveness of measures to control ESBL/AmpC-PB, 
hampering the prioritization of procedures, is the biggest concern we are facing nowadays.  
Furthermore, since new antimicrobials classes have not been discovered since the 70’s 
(Aminov, 2010), the balance between the pros and cons of the way antibiotics are used needs 
to be rethought.   
During the last years, the scientific community turned its attention to the possibility of 
foodborne sources, especially meat, being vastly implicated in the human ESBL/AmpC-PB 
infection cases, neglecting the importance of other potential sources. Furthermore, the use of 
cephalosporins as a driving force for the occurrence of this resistance is becoming not 
highlighted has it should. As Ewers et al. (2012) stated: “The opinion that animal ESBL-
producing E. coli is a major source of human infections is oversimplified, and neglects a highly 
complex scenario”. 
Thus, it is necessary to scrutinize the contribution of other possible sources; principally 
considering that meat seems not to be as relevant as firstly was predicted, at least in some 
country cases. 
Control measures to face this situation are urgently needed and should be set on a global 
scale. 
For a better understanding of the theme, several areas of scientific knowledge (Human and 
Veterinary Medicine, Microbiology, Pharmacology, Genetics, among others) should collaborate 
in order to improve the knowledge on ESBL/AmpC-PB. A broad perspective is required to 
achieve solutions for this public health problem. 
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APPENDIX 
 
 
 
 
 
 
 
 
  
 I 
 
APPENDIX I – Prevalence Estimations 
Table 2 – Lower limit, mode and upper limit of prevalence calculated for each genotype in each type of meat through beta distribution with a 95% CI. The total number of 
samples for each type of meat performed from 2009 to 2011 for DANMAP is represented by n, while s is the number of positive samples for each genotype in each type of 
meat. For a better understanding and comparison with the uncertainty analysis the genotype prevalence within each type of meat is shown.    
Meat 
type 
Origin 
Total 
number of 
samples 
for each 
type of 
meat n 
Number 
of 
positive 
samples 
for each 
type of 
meat 
Prevalence 
2009-2011 
Genotype 
Number of 
positive 
samples for 
each 
genotype s 
(prevalence)  
Beta Distribution 
Detected 
in 
humans  
(DANMAP 
2011) 
Lower Limit 
of 
Prevalence 
Mode 
Prevalence 
Upper 
Limit of 
Prevalence 
PORK 
Danish 562 7 1.2% 
CTX-M-1 4 (0.7%) 0.4% 0.7% 1.8% Yes 
CTX-M-2 2 (0.4%) 0.2% 0.4% 1.2% No 
Unknown 1 (0.2%) 0.0% 0.2% 0.9% N/A 
(1) 
Others 0 (0.0%) 0.0% 0.0% 0.7% N/A 
(2) 
Imported 448 11 2.4% 
CTX-M-1 9 (2.0%) 1.1% 2.0% 3.8% Yes 
CTX-M-14 1 (0.2%) 0.0% 0.2% 1.3% Yes 
CMY-2 1 (0.2%) 0.0% 0.2% 1.3% Yes 
(3) 
Others 0 (0.0%) 0.0% 0.0% 0.9% N/A 
BEEF 
Danish 382 2 0.5% 
TEM-52 1 (0.3%) 0.0% 0.3% 1.3% No 
CMY-2 1 (0.2%) 0.0% 0.3% 1.3% N/A 
Others 0 (0.0%) 0.0% 0.0% 1.0% N/A 
Imported 298 3 1.1% 
CTX-M-1 3 (1.1%) 0.3% 1.0% 3.0% Yes 
Others 0 (0.0%) 0.0% 0.0% 1.4% N/A 
 II 
 
BROILER 
MEAT 
Danish 440 78 17.8% 
CMY-2 70 (16.0%) 12.7% 16.1% 19.8% Yes 
CTX-M-1 8 (1.8%) 0.9% 1.8% 3.6% Yes 
Others 0 (0.0%) 0.0% 0.0% 0.9% N/A 
Imported 571 255 44.7% 
CMY-2 120 (21.0%) 17.9% 21.0% 24.5% Yes 
CTX-M-1 84 (14.7%) 12.1% 14.5% 17.9% Yes 
SHV-12 31 (5.4%) 3.9% 5.4% 7.5% No 
TEM-52 6 (1.1%) 0.5% 1.1% 2.3% No 
Unknown 6 (1.1%) 0.5% 1.1% 2.3% N/A 
CTX-M-2 5 (0.9%) 0.4% 0.9% 1.9% No 
TEM-20 1 (0.2%) 0.0% 0.2% 0.9% No 
Up-
regulated 
AmpC 
1 (0.2%) 0.0% 0.2% 0.9% No 
SHV-2a 1 (0.2%) 0.0% 0.2% 0.9% No 
Others 0 (0.0%) 0.0% 0.0% 0.7% N/A 
 
(1)
 N/A is applied to “Unknown” genotypes found in meat in DANMAP. It was not possible to determine which was the genotype detected. 
(2)
 N/A is applied to “Others”, since it may include genotypes that were present or not in human samples. 
(3)
 CMY-2 was detected in humans but its prevalence was not possible to calculate. However, it is known that few positive CMY-2 samples were detected. 
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APPENDIX II - Beta Distributions 
 
Danish Beef Danish Beef Danish Beef Imported Beef 
    
CMY-2 TEM-52 Others CTX-M-1 
Imported Beef Danish Pork Danish Pork Danish Pork 
    
Others CTX-M-1 CTX-M-2 Unknown 
 
The x and y axis vary between the displayed graphs. 
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Danish Pork Imported Pork Imported Pork Imported Pork 
    
Others CTX-M-1 CTX-M-14 CMY-2 
Imported Pork Danish Broiler Meat Danish Broiler Meat Imported Broiler Meat 
    
Others CMY-2 CTX-M-1 CMY-2 
Imported Broiler Meat Imported Broiler Meat Imported Broiler Meat Imported Broiler Meat 
    
CTX-M-1 SHV-12 TEM-52 Unknown 
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Imported Broiler Meat Imported Broiler Meat Imported Broiler Meat Imported Broiler Meat 
    
CTX-M-2 TEM-20 SHV-2a AmpC 
Imported Broiler Meat    
 
   
Others    
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APPENDIX III - Other activities enrolled during the internship 
  
NOSOVE 2013 Meeting and Course  
Copenhagen, 14th to 17th January 2013 
The Nordic Society for Veterinary Epidemiology (NOSOVE) annual meeting focused on 
“Introduction to R” and “Advanced prevalence estimation using R”. The course work load was 
equivalent to 1 ECTS. 
  
Seminar about the Danish policy on antimicrobial use in food animals 
Copenhagen, Danish Agriculture & Food Council, 8th February 2013 
Joint meeting between the Danish Veterinary & Food Administration, the Danish Agriculture 
& Food Council and the US delegation to discuss the Danish policy on antimicrobial use in food 
animals, the several initiatives that took place in Denmark in the last few years about this 
subject and their consequences. The American strategy was also revised.  
 
Speaker at the University of Copenhagen 
Copenhagen, University of Copenhagen, 18th February 2013 
Presentation of “Risk Assessment of ESBL in Meat” at the Faculty of Health and Medical 
Sciences of the University of Copenhagen. This lecture was intended for the 4th year Master’s 
Degree on Veterinary Medicine students belonging to the Elite Module and focused on the 
project structure and on the several risk assessment steps according to the OIE approach. 
 
Burden of Foodborne Diseases Seminar 
Copenhagen, Technical University of Denmark, 19th February 2013 
A seminar organized by the National Food Institute and the Technical University of Denmark 
about the state-of-art and the progress made in the last few years on the estimation of the 
burden of disease in several fields of the food science.  
  
ESBL Seminar  
Copenhagen, University of Copenhagen, 1st March 2013 
Speaker and participant on the ESBL seminar at the Population Biology group of the 
University of Copenhagen. This meeting gathered antimicrobial resistance and ESBL experts 
from several scientific areas to present and discuss their knowledge on ESBL. I presented the 
project “Risk Assessment of ESBL in Meat”.  
 
 
 VII 
 
SVEPM Congress 2013  
Madrid, 20th to 22nd March 2013 
The annual congress of the Society of Veterinary Epidemiology and Preventive Medicine 
(SVEPM) took place in Madrid. The lectures covered various topics related to Epidemiology and 
Preventive Medicine. I was enrolled in the “Basic Epidemiological Concepts” workshop by Peter 
Cripps and Kenton Morgan from the University of Liverpool and I also presented the poster 
“Exposure assessment of ESBL in meat” in a poster tour. The poster was awarded one of the 
three Poster Prizes. 
 
Danish Agriculture & Food Council Statistics Group Meeting 
Copenhagen, Axelborg, 11th April 2013 
I was one of the speakers, presenting “ESBL – Exposure assessment used to assess the 
role of meat”. 
 
Workshop on Prezi™ Presentations 
Copenhagen, IT Learning Center, 15th April 2013 
Workshop “Learn to make a Prezi presentation in only two hours” by Loet Rammelsberg and 
Søren Larsen. The practical workshop focused on the basic tools to create a Prezi and present 
it. 
 
Workshop on SimHerd™  
Åarhus, Research Centre Foulum, Åarhus University, 23rd and 24th April 2013 
Workshop with Jan Tind Sørensen, Søren Østergaard, Jehan Ettema and Anne Kudahl on 
SimHerd™. The programme had a very strong practical component, focusing on the creation of 
scenarios, interpretation of results and possible uses of the model. 
 
Presentation of the project 
Copenhagen, Danish Agriculture and Food Council, 29th April 2013 
Presentation of the project to 4th year veterinary medicine students from the food track in the 
veterinary curriculum at the University of Copenhagen. The draft report was used for a student 
work project within the subject Risk Assessment. 
 
Presentation of the project 
Copenhagen, University of Copenhagen, 30th April 2013 
Presentation of the project to the Population Biology group at Department of Large Animal 
Sciences, Faculty of Health and Medical Sciences, University of Copenhagen.   
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APPENDIX IV - Poster Prize Winner SVEPM Madrid 2013 
 
 
 
